DexCom Profile

USD 0.47  0.72%

Sale by Blickenstaff Kim D of 500 shares of DexCom

DexCom Inc insider trading alert for sale of common stock by Blickenstaff Kim D, the corporate stakeholder, on March 20, 2018. This event was filed by Dexcom Inc with SEC on 2006-03-13. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

DexCom Summary

DexCom Inc (DXCM) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 2,290 people. DexCom is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 5.71 B. DexCom Inc conducts business under Healthcare sector and is part of Medical Equipment industry. This company has 87 M outstanding shares of which 12.17 M shares are currently shorted by private and institutional investors with about 7.5 trading days to cover. DEXCOM currently holds about 548.6 M in cash with 92 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.31.
Check DexCom Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected DexCom Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

DexCom Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 1% 
Equity ratings for DexCom Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DexCom operates under Medical Laboratories Research classification in USA and traded on NASDAQ. It employs 2290 people. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
NameDexCom Inc
CEO and President and DirectorKevin SayerView All
Thematic ClassificationMedical EquipmentView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Medical Equipment
InstrumentUSA Stock View All
RegionNorth America
Business Address6340 Sequence Drive
CIK Number01093557.0
IndustryMedical Equipment
Contact Number858 200 0200
CurrencyUSD - US Dollar


DexCom Analyst Recommendations
Target PriceAdvice# of Analysts
DexCom Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
DexCom Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


DexCom Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.18April 26, 2017
DexCom Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


DexCom Corporate Directors
Eric Topol Independent Director, Ph.D
Nicholas Augustinos Independent Director
Mark Foletta Independent Director, CPA